Showing 1 - 4 results of 4 for search 'Misato Hashizume', query time: 0.02s Refine Results
  1. 1
    Outlook of IL-6 signaling blockade for COVID-19 pneumonia

    Outlook of IL-6 signaling blockade for COVID-19 pneumonia by Misato Hashizume

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).

    Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Ce... by Keisuke Izumi, Yuko Kaneko, Misato Hashizume, Keiko Yoshimoto, Tsutomu Takeuchi

    Published 2016-01-01
    Get full text
    Article
  3. 3
    Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).

    Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospec... by Keisuke Izumi, Yuko Kaneko, Misato Hashizume, Keiko Yoshimoto, Tsutomu Takeuchi

    Published 2015-01-01
    Get full text
    Article
  4. 4
    Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate

    Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate by Alison O’Mahony, Markus R. John, Hannah Cho, Misato Hashizume, Ernest H. Choy

    Published 2018-06-01
    Get full text
    Article

Search Tools: